Applying an Ethical Framework to Herbal Medicine by Chatfield, Kate et al.
Review Article
Applying an Ethical Framework to Herbal Medicine
Kate Chatfield,1 Bahare Salehi ,2,3 Javad Sharifi-Rad ,4,5 and Leila Afshar6
1Centre for Professional Ethics, University of Central Lancashire, Preston, UK
2Medical Ethics and Law Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5Department of Chemistry, Richardson College for the Environmental Science Complex,
The University of Winnipeg, Winnipeg, MB, Canada
6Department of Medical Ethics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Correspondence should be addressed to Bahare Salehi; bahar.salehi007@gmail.com
and Javad Sharifi-Rad; javad.sharifirad@gmail.com
Received 29 June 2018; Accepted 2 September 2018; Published 19 September 2018
Academic Editor: Michał Tomczyk
Copyright © 2018 Kate Chatfield et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Herbal medicines make a vital contribution to healthcare globally, but from production through to practice, there are ethical
challenges that require attention. Ethical challenges are often analysed through application of an ethical framework because this can
facilitate a consistent and structured approach. In healthcare, the most commonly used framework over recent decades has been
that of the four principles: beneficence, nonmaleficence, autonomy, and justice. However, for various reasons that are explained,
this approach to ethical analysis is not the most fitting for the global phenomenon of herbal medicine. In this paper, a relatively
new moral framework that is based upon the globally accepted values of care, respect, honesty, and fairness is explored in relation
to herbal medicine for the first time. Through application of this framework, the ethical challenges and actions needed to address
them become clear, thus resulting in practical recommendations for enhancing ethical standards in herbal medicine.
1. Introduction
Plant-based herbal medications have been valued by cultures
around the world since ancient times, and globally an
estimated 70,000 species of plants are used formedicinal pur-
poses [1]. However, over the last thirty years or so, a number
of potential risks associated with the use of herbal medica-
tions have received growing attention. In particular, there are
concerns that only a tiny fraction of used species have been
subjected to rigorous testing under controlled conditions,
and clinical studies of herbal medicines vary greatly in quality
and usefulness [2]. The aim of this paper is to show how the
application of an appropriate ethical framework can reveal
both the ethical challenges and the actions needed for en-
hanced ethical standards in the production and usage of
herbal medications.
Herbal medicine, also known as botanical medicine or
phytotherapy, involves the use of a plant's seeds, berries,
roots, leaves, bark, or flowers for medicinal purposes, and the
way in which plant-based medicines are used varies greatly
around the world. Herbal medicine can be considered as
either a traditional or a complementary form of treatment,
depending upon where and how it is used. The World
Health Organization (WHO) distinguishes between health-
care interventions that are used in a complementary manner,
away from their geographical origins, and those that are
rooted in local tradition and culture. According to the WHO,
any form of healthcare that is indigenous to a particular
region can be classified as ‘traditional medicine’ within that
locality, but outside that region it may be considered as ‘com-
plementary medicine’ [3]. In high income countries, most
nonconventional medicines are used in a complementary
manner and people who can afford to pay for additional
services choose from a broad range of privately delivered
treatments. In low andmiddle income countries, many forms
of traditional medicine are region-specific, and the types that
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are available are largely dependent upon the accessible flora,
fauna, and other local resources, as well as the local traditions.
When used in a traditional manner, the types of herbs depend
upon the plant species that are local to that region. Hence,
the plants used in traditional herbalmedicine inChinawill be
mostly different from those used in traditional treatments in
African countries [4]. Herbal medications contribute signifi-
cantly to most indigenous forms of medicine, termed ethno-
medicines, and their use is often intertwined with local
customs and beliefs about the workings of the body and
the nature of health and disease [5]. Some types of ethno-
medicine, such asTraditional ChineseMedicine orAyurvedic
medicine, incorporate a range of therapeutic interventions
which are used alongside herbal treatments to form a holistic
package of care. However, in the West, herbal medicine is
more commonly viewed as a discrete therapeutic approach,
even though it is often used at the same time as other treat-
ments (such as conventional medications). When used in this
complementary manner, the herbs may be sourced locally or
they might be imported from across the globe. For instance,
herbal treatments from Africa or China could be used along-
side conventional or other treatments in a European coun-
try.
The WHO suggests that usage of traditional medicines
may be as high as eighty per cent of the population in some
parts of Asia and Africa where many people rely upon some
form of traditional medicine for their primary healthcare [6].
More recently, this high figure has been called into question
[7], but there is little doubt that the global market for herbal
medicine is substantial. In 2016 this was valued at 71.19 billion
US dollars and this figure is predicted to rise in the near
future [8]. The increasing market has been attributed to a
growing preference for ‘natural’ medicines such as Ayurveda,
Unani, and Traditional Chinese Medicine which are largely
comprised of plant-based medicines.
Reported reasons for the increasing the popularity of
herbal medicines as a complementary treatment amongst
Western consumers have included health promotion [9],
avoidance of side effects from conventional treatments [10],
and lack of effective conventional care [11]. Aside from their
desirability as a traditional or complementary treatment, her-
bal medicines also contribute directly to the development
of conventional medications with as many as one-third to
one-half of pharmaceutical drugs being derived from plants
[12]. For example, the drug Vinblastine is derived from
Periwinkle, a plant that is commonly found in Europe and
North Africa. This drug is primarily used as a chemical
agent in many types of cancer. Additionally, with grand chal-
lenges like drug resistance, depletion of fossil fuels, and the
impact of ecological degradation threatening the wide scale
production of conventional drugs, the need to investigate
the full potential of plant-based alternatives has become a
growing imperative [13–32]. The vital contribution of plant-
based medicines to our pharmacopoeia for both current
and future generations is undeniable. Still, given that most
herbal medicines are underresearched in terms of efficacy,
safety, and cost effectiveness, this inevitably generates ethical
concerns.
2. The Primary Ethical Challenges for
Herbal Medicine
Asignificant number of people hold themistaken assumption
that herbal products are safe because they are natural [33, 34],
but herbal medicines have pharmacological effects, just like
synthetic pharmaceuticals. Many plants are potent or toxic
and there is typically far less safety data available for herbal
products than would be required for conventional medi-
cations [35]. Some herbal medicines have been associated
with adverse drug reactions including overdose and toxicity
[36, 37], drug/herb interactions [34, 38], allergic reactions
[39], and contamination with other products [40, 41]. Addi-
tionally they have been known to interfere with results from
laboratory tests [39]. Inmost regions of the world, consumers
have access to unlicensed herbal medicines [42], which may
expose them to any of these dangers without the oversight of
an experienced practitioner.
Unlike pharmaceutical drugs, most herbal medicines are
not taken through the phases of development before release
onto the open market. In fact, most herbal medicines have
been in use for substantial periods of time, perhaps even
hundreds or thousands of years, before they are subjected to
clinical studies, if at all. It may seem reasonable to assume
that the extensive use of herbal medicines over long periods
of historical duration should reveal all implications for their
safety. Information about who might be at risk, how much to
take, and potential side effects can be gleaned from years of
real world experience and guidance developed accordingly.
This type of information evolves as it is passed down through
generations and is vital to locally based, traditional forms
of medicine. However, when products are removed from
their cultural and traditional roots and applied in completely
different environments, under different conditions, and in
different formats, the consequences of such use are unpre-
dictable [3]. Even those herbal medications that are relatively
well-studied may not have been tested with certain people,
such as paediatrics, pregnant or lactating women, elderly
people, or those with multiple morbidities [43].
Because most herbal medications are underresearched,
their potential for harm is often unknown [44] and this has
a direct impact upon the informed consent process. When
physicians are unable to provide evidence about efficacy or
the potential for side effects, patients cannot be fully informed
about risks and benefits [45, 46]. Perhaps evenmore alarming
is the allegation that information about herbal medications
can be dangerously misleading [38, 47]. In addition to the
potential for harm from the medications, there are also
concerns about the providers of herbal medicine because, in
many environments, they are not medically trained [44], and
neither are they well regulated [48].
Aside from the impacts upon people, the production
and delivery of herbal medicines has impacts upon local
environments and communities. For instance, the growing
demand for standardised herbal products is putting pressure
on selected high demand species [49] and some plants are in
danger of extinction as a result of demand [50]. A demand-
oriented market and poor quality checks have motivated
certain producers to go for mass production without taking
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into account the consequences of plant cultivation. Further-
more, many medicinal plants are collected from the wild in
an uncontrolled manner because cultivated plants are often
considered inferior [51]. Unsustainable harvesting threatens
the survival of not only medicinal plant species, but also the
people that depend upon them [52]. Along with the growth
in global markets, there has been an increase in biopiracy,
whereby traditional herbal medicines have been patented
without consent or compensation to their holders [12].
It would be both unrealistic and unethical to restrict use
of plant-based medicines to those that have been tested ro-
bustly as this would deny access to medicine for entire com-
munities, particularly in resource-poor areas. In higher-
income regions, where herbal medications are used in a com-
plementary manner, restriction would compromise respect
for individual preferences. Nevertheless, given the aforemen-
tioned ethical challenges for the provision of herbalmedicine,
it is vital that measures that are respectful of individual needs
and preferences are put in place while avoiding harm to
patients, the environment, and local communities.
3. An Ethical Framework for
the Provision of Herbal Medicine
Ethical evaluation is often conducted through the application
of an ethical framework because frameworks can facilitate a
consistent and structured approach. An extremely large num-
ber of ethical frameworks have been developed. Some are
aligned with particular ethical theories, such as the conse-
quentialist framework, the duty framework, and the virtue
framework [53], while others have been developed for use
within certain professions.
Most people who work in healthcare will be familiar with
a framework that is underpinned by the four ethical princi-
ples of beneficence, nonmaleficence, autonomy, and justice.
Together they stipulate that healthcare professionals must
aim to do good, avoid doing harm, respect the right of indivi-
duals to make decisions for themselves, and ensure that
people are treated fairly [54]. This approach, known as prin-
ciplism, has been prominent in biomedical ethics since first
introduced by American scholars, Beauchamp and Childress,
almost 40 years ago. Undoubtedly, principlism has proven
worth, as evidenced by how it has been adopted across health-
care professions, and beyond, to guide professional prac-
tice and research. However, principlism has received a fair
amount of criticism, being perceived by many as being ‘ex-
plicitly American in nature’ [55] and hence not readily appli-
cable across cultures. For instance, the principle of autonomy,
which is interpreted by Beauchamp and Childress as the right
of individuals (who have the mental and physical capacity)
to make decisions for themselves, is not recognised in all
cultures globally; in some cultures, decisions about healthcare
are reached by consensus, rather than by the individual [56].
Given that the production and use of herbal medicine is
a global phenomenon, we propose application of an ethical
framework that has worldwide applicability. Recently, such a
framework has emerged from the work of a global consor-
tium of researchers, academics, research participants, policy
CARE
To feel concern, aﬀection or 
consideration for
RESPECT
To have due regard for the 
customs, wishes and rights of 
others
HONESTY
To be truthful and trustworthy
FAIRNESS
To treat people equally and 
without discrimination
Figure 1
makers, and research ethics committee leads together with
representatives from funding bodies and the pharmaceutical
industry.Their findings suggest the use of a framework that is
based upon values rather than principles, namely, the values
of care, respect, honesty, and fairness as shown in Figure 1 [57].
Principlism has been accused of taking a rather formulaic
approach to ethics that focusses upon the application of
processes rather than upon ‘being ethical’ because it does not
take any account of the virtue and intentions of the person
acting [58].This is not the case with a values approach. Values
describe what people believe to be important and, signifi-
cantly, they are recognised as a driving force in decision-
making. Hence, the values one holds will influence the kinds
of decisions that one makes. Values can vary across cultures
but these particular values have been found to have cross-
cultural agreement and understanding. The values frame-
work was originally developed for application in research
collaborations and has been used to develop two codes of
conduct for research [57, 59] but the four values can equally
provide a foundation for analysis of ethical concerns across
a broad range of disciplines and scenarios, including the
practice of herbal medicine. At any point in time, those who
work in herbal medicine, in whatever capacity, can reflect
upon whether they are acting with care, respect, honesty, and
fairness. The idea being that, when people hold true to these
values, ethical standards are upheld. Being a relatively new
moral framework, the full potential of this approach is yet
to be explored and in this paper it is considered for herbal
medicine for the very first time. In the following section,
the values are further described with examples of how they
might be enacted in herbal medicine to ensure high ethical
standards.
4. Application of the Four Values to
Herbal Medicine
4.1. Care. Care in herbal medicine is demonstrated through
concern for the welfare of those who use the medications as
well as the communities and environments from which they
are sourced. For practitioners, care requires knowledge and
expertise; practitioners must make judgements about when
particular medications are indicated, are appropriate, and
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are safe. When practitioners are working with incomplete or
inaccurate information, this can lead to harm. Hence, a cru-
cial component of care is a commitment to life-long learning;
practitioners should stay abreast of new developments and
safety information. Additionally, care is shown when practi-
tioners work only within their bounds of competence and use
products from trusted suppliers to ensure quality and ethical
sourcing methods. A further example of care might be seen
in the way in which practitioners communicate with their
patients. For instance, the provision of written information
to an illiterate person exemplifies a distinct lack of care. For
producers of herbal medicine, care entails the preservation
and conservation of local environments and avoiding harm
to local communities. Of course, there are challenges when
acting with care; it may require more time, more effort, better
resources, and easy access to the appropriate information.
4.2. Respect. Respect requires acceptance that people’s pref-
erences, customs, and cultures may be different from one’s
own. In healthcare, it canmean that a provider or practitioner
accepts away of approaching treatment or a decision that they
would not select for themselves.
In cultures where there is traditional usage of herbal
medicines, certain treatments may hold cultural or spiritual
significance for entire communities that are not obvious to
outsiders [60]. There might be greater trust in medications
that have centuries of historical usage [61]. Additionally, deci-
sions about healthcaremay be taken by particularmembers of
a community rather than by individuals, such that respect for
different customs and decision-making processes is necessary
[61].
For individuals who use herbal medicine in a comple-
mentary manner, healthcare providers should respect that
individuals can ‘pick and choose’ a variety of treatments for
different ailments. This may lead to challenges, especially
when there are differing opinions about what will be most
helpful to the patient.
4.3. Honesty. In all cultures and nations, ‘do not lie’ is a basic
prerequisite for ethical human interaction. However, the
value of honesty has a broader scope in the context of
healthcare.Deliberately lying is an obviouswrongdoing, but it
is equally unacceptable to omit important information that is
necessary for informed consent. Hence, herbal practitioners
should be honest and open about the type of evidence that
is available for their treatments in terms of efficacy and the
potential for adverse effects. Gaps in knowledge need to
be revealed. Equally, honesty is necessary in promotional
activities. It would be unethical tomislead patients or promise
cure in circumstances where there is no certainty of benefit.
For herbal practitioners, honesty requires clarity about when
evidence stems purely from traditional usage and when tradi-
tional knowledge has been tested through scientific investiga-
tion.
4.4. Fairness. Fairness can have a number of interpretations
but the most relevant concepts for ethics in herbal medicine
are fairness in distribution, corrective fairness, and fairness in
exchange. Fairness in distribution concerns the availability
of treatments. It implies that the same quality of treatment
should be available to all, regardless of economic or social
status, or any prejudicial factors. Of course, we know that this
is not currently actualised in healthcare. The very reason why
somany people rely upon herbal treatments in resource-poor
settings is because they offer the only affordable and accessi-
ble choice [62]. In environmentswhere people have the ability
to choose herbal medicine as a complementary treatment,
high quality treatment may be priced beyond reach of many.
While practitioners are not in a position to address the grand
challenges that underpin inequity in availability, they can
enact fairness at a local level when they do their best to treat
people equally and without discrimination. Concerning the
other two types of fairness: corrective fairness is about how to
right awrong and includes considerations such as liability and
accountability, and fairness in exchangemight include the fair
charging for services.
5. Recommendations for
Enhanced Ethical Practice in
Herbal Medicine
Even from this very brief consideration of the four values in
relation to herbal medicine, specific challenges for the reali-
sation of high ethical standards are revealed. Some of these,
such as the unequal distribution of quality and availability
around the globe, are beyond the influence of most. However,
there are smaller scale, pragmatic solutions that lie within the
realms of possibility for various stakeholders.
Practitioners can exemplify the four values in their
practice.When they reflect uponwhether they are actingwith
care, respect, honesty, and fairness, shortcomings in ethical
practice may be revealed. For instance, they may conclude
that more effort is required to keep their knowledge up to
date and to contribute to international reporting schemes
for adverse effects such as that of the WHO Programme for
International Drug Monitoring. VigiBase, the WHO global
database of individual case safety reports, relies upon the
reporting of adverse effects by individuals and practitioners
to monitor safety of all drugs, including herbal medications
[63].
For educators, inclusionof avalues approach in their teach-
ing may help to reveal areas where they can contribute to
the improvement of ethical standards. Knowledge and under-
standing of herbal medications form only one component
of what is necessary for ethical care; there are many other
considerations for ethical practice. Furthermore, because the
nature of evidence for most herbal medicines is of such a dif-
ferent quality to that of drugs in conventional medicine, edu-
cators need to address what happens when there are evidence
gaps or variations in reliability. Aside from the education
of herbal practitioners, universities with medical, nursing,
and pharmaceutical programmes can help to improve ethical
standards through development of curriculum on the use
and safety of natural therapeutic products.This would enable
them to discuss the use of herbal medications with their
patients in an informed manner.
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Manufacturers can also implement the four values, taking
care to produce products that are of reliable quality and free
from contamination. Honesty requires the correct labelling
of products and reliable advertising. Fairness would ensure
reasonable pricing as well as reasonable recompense for the
community where the herbs are sourced. Both respect and
care are also needed for ethical sourcing of herbs to ensure
that harm is not caused during the growing, harvesting, and
manufacturing of herbal products.
Lastly, it is clear from this analysis that ethical standards
are compromised greatly by deficiencies in research into
herbal medications. When information is limited, practition-
ers can be working in the dark and patients may have insuf-
ficient information for informed consent. For fully informed
consent, patients must understand the implications of using
herbal medications [64], but in situations where there is little
or no evidence for efficacy or safety, it is impossible formedics
to provide accurate and reliable guidance [65].
Herbal medicine research can provide much needed
information about effectiveness and safety that can be trans-
mitted to the clinical environment and be used to inform
patients. Such research should aim to fill the gaps in available
knowledge [66]. In particular, much more data is needed
about the interaction of herbal medications with other medi-
cations, as well as safety in certain populations, because some
patient groups may be more at risk than others [66].
Comparative testing with existing conventional medica-
tions can reveal important information about effectiveness,
safety, and cost effectiveness. However, for ethical compar-
ative analysis, such comparisons should also include assess-
ment of the broader societal and environmental impacts of
sourcing and manufacturing of each comparator, as well as
respect for patient preferences.
Herbal medicines make a vast contribution to global
healthcare, both as a traditional and a complementary formof
treatment, as well as being important sources of new con-
ventional drugs. In spite of this, globally, investment in her-
bal medicine research is totally out of proportion to global
reliance upon plant-based medications. For instance, in the
United States, funding for National Center for Comple-
mentary and Integrative Health (NCCIH) research activity
in 2015 amounted to $124 million while total funding of
health research and development activity in the United States
amounted to $158,716 million [67], indicating that NCCIH
funding is equivalent to less than 0.08% of all medical
research funding. Funding for wide scale herbal medicine
research, of the type that would be needed to develop a robust
evidence base, is simply not available.
However, in some countries, particularly where the use of
traditional forms of ethnomedicine are more widespread and
culturally embedded, there appears to be a greater inclination
and endeavour towards improving quality, regulatory, and
ethical standards. For example, in India, the Ministry of
AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha
and Homeopathy) was established in 2014 to improve stan-
dards, inter alia, in education, research, cultivation of medic-
inal plants, and pharmacopoeia standards of these healthcare
systems. The most recent AYUSH annual report (2017-2018)
[68] outlines a vision for ‘comprehensive development of
conservation, cultivation, collection, processing, marketing,
research and extension support system’ for medicinal plants.
In addition to this aim, a National Policy on Medicinal
Plants is currently being developed to harmonise the current
disparate governance mechanisms under a single code. The
same annual report describes India as the world’s second
largest exporter of medicinal plants after China, with both
countries together producing more than 70% of herbal
products globally. Hence, it is unsurprising that steps are also
being taken in China to improve standards.
In 2016, the State Council of the People’s Republic of
China published their first white paper on the topic of Tra-
ditional Chinese Medicine [69]. Significantly, this paper de-
clares that equal attention will be paid to traditional and con-
ventional (Western) medicine in terms of regulation, train-
ing, and practice.Thewhite paper also describes recent efforts
to enhance standards in research, in quality and safety, and
to promote green and sustainable development, including the
enactment of new laws and regulations on the protection of
resources in the wild and the protection of rare and endan-
gered species.
Clearly, significant efforts are being made that will im-
prove ethical standards in the use of medicinal plants in
certain countries. However, given that the number of medic-
inal plants is so vast and that the types of plants vary be-
tween locations, many challenges remain for ethical herbal
medicine globally.
6. Conclusion
Application of a simple ethical framework, such as that of
the four values, can be used to reveal ethical challenges for
herbal medicine but also to suggest strategies for enhancing
ethical standards in the production, education, and practice
of herbal medicine. We have made suggestions for how the
values can be realised within each of these activities, but also
key to enhancing ethical practice in herbalmedicine is greater
investment in research. While certain steps can be taken to
ensure that patients are treated with care and respect and that
they are informed about the potential consequences of herbal
treatment, that information is limited by availability. Given
the vast number of plant-based medicines, the acquisition
of pharmacological information and the potential for drug
interactions pose a major challenge, but failure to address
this challenge is tantamount to acceptance of lower ethical
standards for those who choose, or those who rely upon,
herbal medicines.
Finally, we would like to close with the suggestion that
professional bodies, scientists, manufacturers, and ethicists
from around the world work closely together to develop a
more unified strategy for enhancing ethical standards in
herbal medicine globally. The values framework could be
used to help frame such a strategy because it can apply equally
to all aspects from supply chain through to practice.
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